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Background: A hallmark of atherosclerosis is progressive intimal thickening (namely neointimal hyperplasia),
which leads to occlusive vascular diseases. Over-production of reactive oxygen species (ROS) and alteration of
Ca2+ signaling are among the key factors contributing to neointimal growth. In the present study,we investigated
the role of TRPM2, a ROS-sensitive Ca2+ entry channel, in neointimal hyperplasia.
Methods and results: Perivascular cuffs were used to induce neointimal hyperplasia in rat/mouse arteries.
Immunostaining showed numerous TRPM2-positive smooth muscle cells in neointimal regions. ROS were
over-produced and PCNA-positive proliferating cells were numerous in the neointimal regions. The neointimal
hyperplasia was substantially reduced in Trpm2 knockout mice compared with wild-type mice. In the cultured
rat/mouse aortic smooth muscle cells, H2O2 treatment was found to stimulate cell proliferation and migration.
The effect of H2O2 was reduced by a TRPM2-speciﬁc blocking antibody TM2E3 or Trpm2 knockout. The signaling
molecules downstream of TRPM2 were found to be Axl and Akt.
Conclusions: These data suggest a critical functional role of TRPM2 in the progression of neointimal hyperplasia.
The study also highlights the possibility of targeting TRPM2 as a potential therapeutic option for the treatment
of occlusive vascular diseases.© 2015 Elsevier B.V. All rights reserved.1. Introduction
Atherosclerosis is a common medical problem in industrialized
countries and has major impact on survival and quality of life. A
hallmark of atherosclerosis is vascular wall thickening in the intimal
layer, namely neointimal hyperplasia. Neointimal hyperplasia is an
early event in the development of atherosclerotic lesions. Neointimal
hyperplasia narrows vascular lumen, resulting in occlusive vascular
disease, such as coronary artery disease, myocardial infarction and
stroke [1]. Angioplasty with stent placement and bypass surgery arehydroethidium;EdU,5-ethynyl-
anthine–xanthine oxidase; I/M
ockout; p-Akt, phosphorylated
clear antigen; ROS, reactive oxy-
receptor potential channel M2;
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2 26035123.primary treatment options. They are effective in relieving symptoms
(e.g. angina, dyspnea, and fatigue) and reducing mortality. However,
long-term beneﬁts are limited by the formation of neointima in the
stents and vein grafts, leading to in-stent restenosis and vein graft failure
[2–4]. Thus, exploring themolecularmechanism of neointimal hyperpla-
sia and developing novel therapeutic strategies are of signiﬁcance.
Vascular smooth muscle cells (VSMCs) are the major cellular
component of neointima. At the sites of vessel injury, VSMCs in the
media undergo phenotypic switch: dedifferentiate from a quiescent,
contractile phenotype to a proliferative, synthetic phenotype [5].
These VSMCs migrate from the media layer to the intima layer and
proliferate, with increased secretion of extracellular matrix, contribut-
ing to the formation of neointima [5,6]. A key event in atherosclerotic
development is over-production of reactive oxygen species (ROS). ROS
are released from macrophages, neutrophils and vascular cells [7]. ROS
over-production promotes the progression of neointimal hyperplasia
by stimulating multiple pathological events, including VSMC migration
and proliferation, monocyte/macrophage and neutrophil inﬁltration,
inﬂammation, extracellular matrix deposit, and vascular cell death
[8–11]. Ca2+ signaling is another important player in neointimal
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messenger, Ca2+ plays an essential role in proliferation and migration
of VSMCs [12,13]. Injured vascular walls often show an alteration of
Ca2+ signaling pathways in VSMCs, including down-regulation of
L-type Ca2+ channels and up-regulation of T-type Ca2+ channels and
TRPC channels [12].
Transient receptor potential channelM2 (TRPM2) is a Ca2+-permeable
cation channel activated by H2O2, adenosine 5′-diphosphoribose
(ADP-ribose) and Ca2+. The channel is expressed in neurons, VSMCs,
vascular endothelial cells and inﬂammatory cells [14–16]. TRPM2 is
suggested to be a cellular sensor for oxidative stress [17–19]. It has
been reported that H2O2, as a ROS, activates TRPM2 to induce excessiveFig. 1.Neointimal hyperplasia and ROS over-production in cuff-injured rat femoral arteries. (A)
tions of artery were stained with hematoxylin and eosin. The hyperplasia was expressed as the
expressed as mean ± SEM. n= 5. ** p b 0.01 versus sham. (B) Cross sections of artery stained
adventitial-removed artery segments probed with anti-PCNA antibody and anti-β-tubulin antib
of artery stained with dihydroethidium (DHE), a ROS-sensitive ﬂuorescent probe. The ﬂuore
mean ± SEM. n= 4. ** p b 0.01 versus sham. Arrowheads in A and D indicate the internal elasCa2+ inﬂux, resulting in Ca2+ overload and consequent cell death in
neurons, hematopoietic cells and vascular endothelial cells [18,19].
TRPM2 is also involved in inﬂammation. TRPM2-mediated Ca2+ entry
stimulates cytokine production in monocytes, resulting in an aggravat-
ed inﬂammatory response in colon colitis [16].
Based on the crucial role of ROS and Ca2+ signaling in neointimal
hyperplasia, and the property of TRPM2 as a ROS-sensitive Ca2+ entry
channel, in the present study we explored the possible role of TRPM2
in neointimal hyperplasia of blood vessels. In rodentmodels, neointimal
hyperplasia was induced by placing a perivascular cuff (or collar)
around rat/mouse arteries. The results from this study demonstrated
TRPM2 as a key mediator in neointimal growth.Histological analysis showing cuff-induced neointimal hyperplasia in the artery. Cross sec-
ratio of the intimal area to themedial area (I/M ratio) and displayed on the right. Data are
with anti-proliferating cell nuclear antigen (PCNA) antibody. n= 5. (C) Western blot of
ody. Data are expressed asmean± SEM. n=3. ** p b 0.01 versus sham. (D) Cross sections
scent intensity of sham-operated artery was normalized to 100%. Data are expressed as
tic lamina, which forms a boundary between arterial intima and media.
Fig. 2. TRPM2up-regulation in the neointimal region of cuff-injured rat femoral arteries. (A) Cross sections of artery stainedwith anti-TRPM2 antibody showing numerous TRPM2-positive
cells in the neointima and the adjacentmedia region. n=4. (B)Western blot of adventitial-removed artery segments probedwith anti-TRPM2 antibody and anti-β-tubulin antibody. Data
are expressed asmean± SEM. n=4. ** p b 0.01 vs. sham. (C) Double immunoﬂuorescent labeling of the arterywith anti-α-smoothmuscle actin (α-SMA) antibody (red) and anti-TRPM2
antibody (green). Arrowhead indicates the internal elastic lamina. n = 5. (D) Representative traces of [Ca2+]i (left) and summary of peak [Ca2+]i (right) rises in response to HX–XO
(100 μM HX + 20 mU/ml XO) in freshly prepared SMCs. (E) Representative traces of the [Ca2+]i (left) and summary of peak [Ca2+]i (right) showing effect of TM2E3 (10 μg/ml) or
pre-immune IgG (10 μg/ml, as control) on HX–XO-induced [Ca2+]i rise. In bar charts, data are expressed as mean ± SEM. n= 4 (D) and 5 (E) independent experiments (15 to 30 cells
per experiment). ** p b 0.01. Cuff, neointimal SMCs from cuff-injured arteries; Sham, normal medial SMCs from sham-operated arteries.
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2.1. Chemicals and antibodies
Unless stated, all chemicals were purchased from Sigma. Akt inhibi-
tor IV, Akt inhibitor X, mouse monoclonal anti-proliferating cell nuclear
antigen (PCNA) antibody, goat polyclonal anti-Axl antibody, rabbit
polyclonal anti-β-tubulin antibody, mouse monoclonal anti-β-actin an-
tibody, and horseradish peroxidase-conjugated donkey anti-goat IgG
were obtained from Santa Cruz Biotechnology. R428 was obtained
from Selleck Chemicals. Mouse monoclonal anti-α-smooth muscle
actin (α-SMA) antibody was obtained from Dako. Rabbit monoclonal
anti-α-SMA antibody, biotinylated goat anti-rabbit IgG and biotinylated
goat anti-mouse IgG were obtained from Abcam. Rabbit monoclonal
anti-phospho-Axl antibody, rabbit polyclonal anti-Akt antibody and
rabbit polyclonal anti-phospho-Akt antibody were obtained from Cell
Signaling Technology. Alexa Fluor 555 donkey anti-mouse IgG and
Alexa Fluor 488 goat anti-rabbit IgG were obtained from Invitrogen.
Horseradish peroxidase-conjugated anti-rabbit IgG and horseradish
peroxidase-conjugated anti-mouse IgG were obtained from Amersham
Pharmacia Biotech. Antibodies against TRPM2 were the home-madeFig. 3. Reduced neointimal hyperplasia in cuff-injured carotid artery of Trpm2 knockout mice.
internal elastic lamina. The hyperplasia was expressed as I/M ratio and displayed on the right.
ventitial-removed artery segments probed with anti-TRPM2 antibody and anti-β-tubulin antib
tial-removed artery segments probed with anti-PCNA antibody and anti-β-tubulin antibody.
KO, Trpm2 knockout.rabbit polyclonal anti-TRPM2 antibody and TM2E3 antibody. Anti-
TRPM2 antibody targets to an epitope in the N terminus of TRPM2
(ILKELSKEEEDTDSSEEMLA) [20]. TM2E3 antibody targets to amino
acid residues in E3 region of TRPM2 [21]. Pre-immune IgG was also
home-made.2.2. Animals
Male Sprague–Dawley (SD) rats were obtained from the Laboratory
Animal Services Center, the Chinese University of Hong Kong, Hong
Kong, China. In Trpm2 knockout mice, the Trpm2 gene was disrupted
by deleting the exon that contributes to the putative pore region of
the TRPM2 [16]. Animals were kept in speciﬁc pathogen-free environ-
ment where lighting was controlled (12:12-hour light–dark cycle) and
temperature was maintained at 22–23 °C, with free access to tap
water and standard rodent diet. All animal experimentswere conducted
in conformitywith the Guide for the Care andUse of Laboratory Animals
published by the US National Institute of Health, and the procedures
were approved by the Animal Experimentation Ethics Committee, the
Chinese University of Hong Kong.(A) Cross sections of artery stained with hematoxylin and eosin. Arrowheads indicate the
Data are expressed as mean ± SEM. n= 4. * p b 0.05, ** p b 0.01. (B) Western blot of ad-
ody. Data are expressed as mean ± SEM. n= 3. ** p b 0.01. (C) Western blot of adventi-
Data are expressed as mean ± SEM. n= 4. * p b 0.05, ** p b 0.01. WT, wild-type; Trpm2
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The surgical procedures of cuff-induced artery injurywere performed
according to previously described methods [22,23] with slight modiﬁca-
tions. Brieﬂy, for rat femoral artery cuff placement, SD rats (8 week old)
were anesthetizedwith sodiumpentobarbital (50mg/kg, i.p.). The femo-
ral artery of rat was isolated from the surrounding tissues under a dissec-
tion microscope. A polyethylene tube (length, 5 mm, inner diameter,
0.86 mm; outer diameter, 1.27 mm; Becton Dickinson and Company)
was opened up longitudinally and loosely placed around the artery. The
contralateral femoral artery of the same ratwas used as control, undergo-
ing isolation but without cuff placement (sham operation). Then the
surgical site was sutured with a 6-0 polypropylene suture. 2 weeks
after the surgery, the rats were sacriﬁced by CO2-asphyxia and the
femoral arteries were harvested for study. For mouse carotid artery
cuff placement, the Trpm2 knockout mice (12 week old) and their
wild-type counterparts were anesthetized with ketamine/xylazine (80/
10mg/kg, i.p.). The carotid arterywas isolated and a smaller polyethylene
tube (length, 2–3 mm, inner diameter, 0.58 mm; outer diameter,
0.965 mm; Becton Dickinson and Company) was used as the cuff.
3 weeks after the surgery, the mice were sacriﬁced by CO2-asphyxia
and the carotid arteries were harvested.
2.4. Generation of TRPM2-speciﬁc blocking antibody TM2E3 and
preimmune IgG
TM2E3 antibody was raised in rabbit using the strategy developed
by Xu et al. [21]. Brieﬂy, a peptide corresponding to the TRPM2 putativeFig. 4. Role of TRPM2 in H2O2-stimulated migration of rodent aortic SMCs. (A) Immunoﬂuores
tured rat andmouse aortic SMCs. Nuclei were stainedwith DAPI (blue). (B) and (C) Scratchwou
migration of rat aortic SMCs (B) and effect of Trpm2 knockout on H2O2 (10 μM)-induced migr
expressed as the percentage of closed wound area after incubation for 48 h. Data are expresse
WT, wild-type; Trpm2 KO, Trpm2 knockout.pore region was synthesized and conjugated to a keyhole limpet hemo-
cyanin (KLH) at the Alpha Diagnostic International. The coupled TM2E3
peptide (0.5 mg) was injected subcutaneously in the back of a rabbit
followed by two boost doses. TM2E3 antiserum was collected 4 weeks
after the second boost. IgG was puriﬁed from the TM2E3 antiserum
using a HiTrap Protein G column (GE Healthcare). For control,
pre-immune IgG was obtained from pre-immune serum with HiTrap
Protein G column.
2.5. Histological analysis and immunohistochemistry
The harvested rat femoral arteries and mouse carotid arteries were
ﬁxed in 4% paraformaldehyde and embedded in parafﬁn. 5 μm trans-
verse sections were cut and hematoxylin and eosin (HE) staining was
performed. The areas of intima andmedia weremeasured using ImageJ
software and the ratio of the intimal area to the medial area (I/M ratio)
was calculated.
To explore the cell cycle activity and expression level of TRPM2 in
neointima, immunohistochemical labeling of PCNA and TRPM2 was
performed. 5 μm parafﬁn-embedded rat femoral artery sections were
incubated with anti-TRPM2 antibody (10 μg/ml) or anti-PCNA antibody
(1:100) overnight at 4 °C. Sectionswere then incubatedwith biotinylat-
ed secondary antibodies, and ﬁnally horseradish peroxidase-labeled
streptavidin. Signals were visualized by peroxidase–diaminobenzidine
reaction. The involvement of VSMCs was assessed by double immuno-
ﬂuorescent labeling of TRPM2 and α-SMA in sections of rat arteries.
Anti-TRPM2 antibody (10 μg/ml) and mouse anti-α-SMA antibody
(1:100) were applied to 5 μm parafﬁn-embedded sections overnightcent labeling with anti-α-SMA antibody (green), verifying the identity of the primary cul-
nd healing assay showing inhibitory effect of TM2E3 (10 μg/ml) onH2O2 (10 μM)-induced
ation of mouse aortic SMCs (C). Dashed lines denote the wound edge. Cell migration was
d as mean ± SEM. n= 6 (B) and 4 (C) independent experiments. * p b 0.05, ** p b 0.01.
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rabbit IgG and Alexa Fluor 555 donkey anti-mouse IgG. Fluorescence
was monitored using a laser scanning confocal microscope (FV1000,
Olympus). For these immunostaining experiments, speciﬁcity of signals
was conﬁrmed by replacing primary antibodies with the matched
pre-immune IgG.
2.6. Western blotting
Tissue lysates of intimal and medial layers of rodent arteries and
whole-cell lysates of rodent aortic smooth muscle cells (SMCs) wereFig. 5. Role of TRPM2 in H2O2-stimulated proliferation of rodent aortic SMCs. (A) and (B) EdU in
H2O2 (10 μM)-induced proliferation of rat (A) andmouse (B) aortic SMCs. Nuclei were stained w
itive cells (red). Data are expressed asmean± SEM. n=7 (A) and 9 (B) independent experime
Trpm2 knockout on H2O2 (10 μM)-induced proliferation of rat (C) and mouse (D) aortic SMC
expressed as mean ± SEM. n= 6 independent experiments. ** p b 0.01. In D, WT group in the
dependent experiments. ** p b 0.01. (E) Western blot of aortic SMCs probed with anti-PCN
p b 0.01. WT, wild-type; Trpm2 KO, Trpm2 knockout.extracted with protein extraction buffer. Protein concentrations were
determined by Bradford assay. Proteins were separated on 7.5% SDS-
PAGE gels and transferred to PVDF membranes, and probed with
anti-TRPM2 antibody (2 μg/ml), anti-PCNA antibody (1:500), anti-Axl
antibody (1:1000), anti-phospho-Axl antibody (1:1000), anti-Akt
antibody (1:1000) or anti-phospho-Akt antibody (1:1000) followed
by the appropriate horseradish peroxidase-conjugated secondary anti-
bodies. Immunolabeling was visualized by ECL plus Western blotting
detection reagents (Amersham Pharmacia Biotech). Immunoblots
with anti-β-tubulin antibody (1:500) or anti-β-actin antibody (1:500)
were performed to get internal controls.corporation assay showing inhibitory effect of TM2E3 (10 μg/ml) and Trpm2 knockout on
ith Hoechst 33342 (blue). Cell proliferation was expressed as the percentage of EdU-pos-
nts. ** p b 0.01. (C) and (D)MTT assay showing inhibitory effect of TM2E3 (10 μg/ml) and
s. In C, pre-immune IgG group in the absence of H2O2 was normalized to 100%. Data are
absence of H2O2 was normalized to 100%. Data are expressed as mean ± SEM. n= 4 in-
A antibody and anti-β-tubulin antibody. Data are expressed as mean ± SEM. n = 3. **
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Fresh frozen sections (10 μm) of rat femoral arteries were incubated
with DHE (5 μM) for 10min at 37 °C. Fluorescencewasmonitored using
FV1000 laser scanning confocal imaging system (Olympus) at
excitation/emission of 488/605 nm. Fluorescent intensity in the arterial
intimal and medial area was analyzed by the Fluoview software
(Olympus).
2.8. Isolation of smooth muscle cells from neointimal and medial layers
Cuff-injured rat femoral arteries and their sham-operated controls
were excised. Under an operatingmicroscope, the arteries were cleaned
from connective tissue and cut longitudinally. The endothelium was
gently removed mechanically. Then neointima of cuff-injured arteries
was scraped. The tissues were digested with 0.2% collagenase type IA,
0.9% papain, 0.5% BSA and 10 mM dithiothreitol in Ca2+-free PBS at
37 °C. The isolated VSMCs were seeded onto round cover slips in
12-well plates and cultured with DMEM supplemented with 1% fetal
bovine serum (FBS), penicillin and streptomycin (100 U/ml and
100 μg/ml, respectively), and 1% L-glutamine for 8 h before [Ca2+]i mea-
surement. For sham-operated arteries, the VSMCs were isolated from
medial layer as control in [Ca2+]i study.
2.9. Culture of rodent aortic smooth muscle cells
Rodent aortic SMCswere obtained using explantmethod as described
elsewhere [24] with slight modiﬁcations. Brieﬂy, SD rat (6 week old),
Trpm2 knockout mice (4 week old) and wild-type mice (4 week old)
were sacriﬁced by CO2-asphyxia. The aortic arteries were excised under
sterile conditions. Vessel lumens were opened longitudinally and theFig. 6. TRPM2mediates H2O2-induced [Ca2+]i rise in rodent aortic SMCs. Representative traces o
[Ca2+]i rise was inhibited by TM2E3 (10 μg/ml) in rat aortic SMCs (A) and was reduced in Trpm
(B) independent experiments (15 to 30 cells per experiment). ** p b 0.01. WT, wild-type; Trpmendothelium was removed mechanically. The arteries were cut into
small pieces (2 mm × 2 mm), and placed in 35 mm culture dishes with
lumen side down and with a distance of 5 mm from each other. The ex-
plants were allowed to air dry to adhere and then cultured with DMEM
supplemented with 10% FBS, penicillin and streptomycin (100 U/ml and
100 μg/ml, respectively), and 1% L-glutamine. The culture medium was
replaced every 3–4 days. Aortic SMCs grew out from the explants and
achieved conﬂuence after approximately 7 days. Cells were harvested
with trypsin and used for experiments at passage 2–4. Cell identity was
veriﬁed by immunoﬂuorescent staining of α-SMA using the rabbit anti-
α-SMA antibody (1:100).2.10. [Ca2+]i measurement
SMCs were loaded with a membrane permeant ﬂuorescence dye
Fluo-4/AM (Molecular Probes) to measure [Ca2+]i responses to hypo-
xanthine–xanthine oxidase (HX–XO) or H2O2. Brieﬂy, the cells were
seeded on round cover slips and were incubated with 5 μM Fluo-4/AM
and 0.02% Pluronic acid F-127 in normal physiological saline solution
(NPSS) for 1 h at room temperature. NPSS contained in mM: 1 CaCl2,
140 NaCl, 1 KCl, 1 MgCl2, 10 glucose, and 5 HEPES, pH 7.4. If needed,
the cells were pre-treated with TM2E3 (10 μg/ml) or preimmune IgG
as control (10 μg/ml) at 37 °C for 2 h. The cover slips were then pinned
in a specially designed chamber and bathed in NPSS. HX–XO (100 μM
HX + 20 mU/ml XO) or H2O2 (500 μM) were applied to the bath
along the side of the chamber. The Fluo-4 ﬂuorescence was recorded
using a FV1000 laser scanning confocal imaging system at excitation/
emission of 488/515 nm at room temperature. The [Ca2+]i response
was expressed as a ratio of real-time ﬂuorescence intensity relative to
the basal intensity before HX–XO or H2O2 was applied (F1/F0).f [Ca2+]i (left) and summary of peak [Ca2+]i (right) showing that H2O2 (500 μM)-induced
2 knockout mouse aortic SMCs (B). Data are expressed as mean ± SEM. n= 6 (A) and 5
2 KO, Trpm2 knockout.
Fig. 7. Effect of EGTA on H2O2-stimulated migration and proliferation of rodent aortic
SMCs. EGTA (3 mM) was applied into the culture medium and maintain the extracellular
Ca2+ concentration at ~80 nM. (A) Scratch wound healing assay showed that EGTA
inhibited H2O2 (10 μM)-induced migration of aortic SMCs from rat and wild-type
mouse. Dashed lines denote the wound edge. Cell migration was expressed as the
percentage of closed wound area after incubation for 48 h. Data are expressed as
mean ± SEM. n = 6 independent experiments. ** p b 0.01. (B) MTT assay showed that
EGTA abolished H2O2 (10 μM)-induced proliferation of aortic SMCs from rat and wild-
type mouse. Data are expressed as mean ± SEM. n = 6 independent experiments. **
p b 0.01. WT, wild-type.
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Cell migration was evaluated using scratch wound healing assay.
Rodent aortic SMCs were seeded in a 6-well plate and cultured to
N95% conﬂuence. Cells were synchronized with 0.5% FBS DMEM for
24 h. An approximately 1 mm cleft (wound) was scratched into cell
monolayer with a sterile pipette tip and medium was replaced with
0.5% FBSDMEMcontaininghydroxyurea (5mM, to prevent cell prolifer-
ation) [25] and H2O2 (10 μM), with/without the present of TM2E3
(10 μg/ml), Akt inhibitor IV (5 μM) or Akt inhibitor X (10 μM). After
incubation for 48 h, for each well, three ﬁelds with the wound area
were chosen and photographed using a microscope coupled to a digital
camera. Percentage of the closed wound area which indicates the cell
migration was analyzed using ImageJ software.
2.12. Cell proliferation assay
Cell proliferation was determined with 5-ethynyl-2′-deoxyuridine
(EdU) incorporation assay. Rodent aortic SMCs were seeded in a
24-well plate. After achieving 50% conﬂuency, cells were synchronized
with 0.5% FBS DMEM for 24 h and then treated with H2O2 (10 μM)
and EdU (10 μM) in 0.5% FBS DMEM, with/without the present of
TM2E3 (10 μg/ml). After incubation for 48 h, cells were ﬁxed, perme-
abilized, and incubated with reaction cocktail of Click-iT Plus EdU
Imaging Kits (Life Technologies) for 30 min. For nuclear staining, the
cells were incubated with Hoechst 33342 (5 μg/ml) for 30 min.
The cells were imaged by a laser scanning confocal imaging system
(Olympus FV1000). Cell proliferation was expressed as the percentage
of EdU-positive cells.
In another set of experiment, MTT (3-(4,5-dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide) assay was also used to determine
cell proliferation. Rodent aortic SMCs were seeded in a 96-well plate.
After achieving 50% conﬂuency, cells were synchronized with 0.5% FBS
DMEM for 24 h and then treated with H2O2 (10 μM) in 0.5% FBS
DMEM, with/without the present of TM2E3 (10 μg/ml), Akt inhibitor
IV (5 μM) or Akt inhibitor X (10 μM). After incubation for 48 h, cells
were further incubated with MTT (0.5 mg/ml) in FBS-free DMEM for
4 h. Then the MTT solution was removed and an equal volume of
dimethyl sulfoxide was added to each well to dissolve purple formazan
crystals. The absorbance was measured at 570 nm using a Microplate
Reader. Cell proliferation was expressed as percentage of the relevant
controls.
2.13. Statistical analysis
All values are expressed as mean ± SEM. The data for each condition
were from at least three independent experiments. Statistical differences
were determined using paired or unpaired Student's t-test, or one-way
ANOVA followed by the Newman–Keuls test. Differences were consid-
ered signiﬁcant at p b 0.05.
3. Results
3.1. ROS over-production and TRPM2 up-regulation in neointima of
cuff-injured rat femoral arteries
To determine whether TRPM2 is potentially involved in neointimal
hyperplasia, we ﬁrst studied a rat model of cuff-induced intimal thick-
ening. A perivascular cuff was placed around rat femoral arteries.
2 weeks after cuff placement, distinct neointimal formation was
observed (Fig. 1A), with markedly increased I/M ratio (0.35 ± 0.04 in
cuffed arteries vs. 0.04 ± 0.01 in contralateral sham-operated arteries.
p b 0.01, n = 5). Immunostaining showed a great number of PCNA-
positive cells in the neointimal and its adjacent media region
(Fig. 1B). Immunoblots of adventitial-removed arteries conﬁrmed
the up-regulation of PCNA protein expression in cuffed rat femoralarteries (Fig. 1C), which indicated the enhanced cell cycle activity in
cuff-injured arteries. The in situ ROS production in arteries was
determined with the ﬂuorescent probe DHE, which intercalates to
DNA and emits red ﬂuorescence when oxidized by superoxide anion
[26]. DHE signal was markedly increased in the neointima and media
1368 X. Ru et al. / Biochimica et Biophysica Acta 1852 (2015) 1360–1371of cuff-injured arteries (Fig. 1D), suggesting a ROS over-production
during hyperplasia.
TRPM2 expression was examined. Numerous TRPM2-positive cells
were found in the neointimal and the adjacent medial regions in cuff-
injured arteries (Fig. 2A). Immunoblots of adventitial-removed arteries
conﬁrmed an up-regulation of TRPM2 protein expression in intimal and
medial layers of cuff-injured arteries (Fig. 2B). Alpha-SMAwas used as a
marker of SMCs. Double immunoﬂuorescent labeling showed consider-
able overlap of TRPM2 andα-SMA signals (Fig. 2C), indicating that these
TRPM2-positive cells are predominantly SMCs. These data demonstrate
that up-regulated expression of TRPM2 in SMCs is an accompaniment of
neointimal formation.
We further measured the ROS-induced [Ca2+]i rises in freshly
isolated neointimal SMCs andnormalmedial SMCs. ROSwere generated
by application of HX–XO system [7]. Compared with the normal SMCs
from sham-operated artery, neointimal SMCs from cuff-injured artery
showed a larger [Ca2+]i rise in response to HX–XO (Fig. 2D). TM2E3 is
a home-made blocking antibody against TRPM2 [21,27]. Previously,
we have shown that TM2E3 is speciﬁc to TRPM2 and can effectivelyFig. 8. TRPM2 mediates H2O2-induced activation of Axl/Akt pathway in rat aortic SMCs. (A) an
(10 μM)-stimulated cell migration (A) and proliferation (B). Cell migration and proliferation
expressed as mean ± SEM. n = 6 independent experiments. ** p b 0.01. (C) Axl and Akt p
(D) H2O2 (500 μM)-induced phosphorylation of Axl and Akt was inhibited by TRPM2-blocking
phosphorylated Axl; p-Akt: phosphorylated Akt; Pre-imm, pre-immune IgG.inhibit the activity of TRPM2 channel [27]. Pre-treatment with TM2E3
(10 μg/ml) for 2 h markedly suppressed the HX–XO-induced [Ca2+]i
rise in SMCs derived from neointimal regions, indicating abundant
presence of functional TRPM2 channels in these cells. TM2E3 also
caused a small inhibition on HX–XO-induced [Ca2+]i rise in SMCs
derived from sham-operated arteries, suggesting the existence of
TRPM2 channels in normal VSMCs. Notably, when TRPM2 was blocked
by TM2E3, no difference was showed in the amplitude of [Ca2+]i
responses between the neointimal SMCs and the normal SMCs, which
indicates that the up-regulated TRPM2 in neointimal SMCs is largely
responsible for the enhanced [Ca2+]i response to ROS (Fig. 2E).
The speciﬁcity of two antibodies, the anti-TRPM2 antibody used in
immunoblots and in tissue section immunostaining and TM2E3 used
in functional blockage, were further conﬁrmed. In immunoblots, both
antibodies could recognize the targeted band with expected molecular
weight of ~170 kDa in the aortic SMCs from wild-type mice but not in
those from Trpm2 knockout mice (Supplementary Fig. 1A). In addition,
the anti-TRPM2 antibody could stain the aortic SMCs from wild-type
mice but not those from Trpm2 knockout mice (Supplementary Fig. 1B).d (B) Akt inhibitor IV (Akt IV, 5 μM) and Akt inhibitor X (Akt X, 10 μM) reduced the H2O2
was evaluated using scratch wound healing assay and MTT assay, respectively. Data are
hosphorylation was induced by H2O2 (500 μM) in a time-dependent manner. n = 4.
antibody TM2E3 (10 μg/ml), EGTA (3 mM) and Axl inhibitor R428 (5 μM). n= 4. p-Axl:
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mice
A mouse model of cuff-induced neointimal hyperplasia was also
established in carotid arteries of Trpm2 knockout mice and their
wild-type counterparts. There was no visual difference between Trpm2
knockout mice and wild-type mice in general appearance or behavior.
Clear neointimal formation was observed in carotid arteries 3 weeks
after cuff placement in wild-type mice (Fig. 3A). Immunoblots of
adventitial-removed arteries showed an up-regulated expression of
TRPM2 protein in cuff-injured arteries (Fig. 3B). In comparison, the
neointimal growth was much less in cuffed carotid arteries from
Trpm2 knockout mice. The I/M ratio was 0.44 ± 0.06 for cuffed arteries
from wild-type mice and 0.20 ± 0.04 for cuffed arteries from Trpm2
knockout mice (p b 0.01, n = 4) (Fig. 3A). Furthermore, cuff-induced
up-regulation of PCNA protein expression in the arteries was much
less in Trpm2 knockout mice than in wild-type mice (Fig. 3C). These
data suggest a crucial role of TRPM2 in cell proliferation and neointimal
growth.
3.3. Role of TRPM2 in ROS-induced VSMC migration and proliferation
Then we tried to explore the underlying mechanisms of TRPM2
involvement in neointimal hyperplasia. Since the above data showed
that ROS were largely produced and TRPM2-expressing VSMCs were a
predominant component in neointima, we then examined the effect of
TRPM2-blocking antibody TM2E3 and Trpm2 disruption on H2O2-
induced VSMC migration and proliferation. Rat and mouse aortic SMCs
were obtained using explant method. Immunostaining with anti-α-
SMA antibody veriﬁed that N95% of the cells were SMCs (Fig. 4A).
In scratch wound healing assay, H2O2 treatment (10 μM, 48 h)
enhanced the migration of rat and mouse aortic SMCs, as indicated by
an increase of closed wound area. TM2E3 (10 μg/ml) inhibited the
H2O2-induced wound recovery of rat aortic SMCs. The wound recovery
was also reduced in aortic SMCs from Trpm2 knockout mice compared
with those from wild-type mice. In addition, basal migration in theFig. 9. Schematic diagram showing the functional role of TRPM2 channels in VSMC migration,
(ROS) over-production, which activates the ROS-sensitive TRPM2 channels. Ca2+ inﬂux throug
pathway eventually causes VSMC migration and proliferation which contributes largely to n
Ca2+ inﬂux induces phosphorylation of Axl and Akt remains unknown.absence of H2O2 was also reduced by TM2E3 and Trpm2 knockout
(Fig. 4B, C). The results from both EdU incorporation assay (Fig. 5A, B)
and MTT assay (Fig. 5C, D) showed that H2O2 treatment substantially
promoted the proliferation of rat and mouse aortic SMCs. H2O2
treatment also enhanced the expression level of PCNA protein in these
cells, which is another indicator for cell proliferation (Fig. 5E). TM2E3
inhibited the H2O2-stimulated proliferation of rat aortic SMCs (Fig. 5A,
C). H2O2-stimulated cell proliferation was also reduced in Trpm2
knockout mice compared with wild-type mice (Fig. 5B, D).
Functional existence of ROS-sensitive TRPM2 channels in rodent
aortic SMCs was veriﬁed. H2O2 evoked distinct [Ca2+]i rise in both rat
and mouse aortic SMCs (Fig. 6A, B). Pre-treating rat aortic SMCs with
TM2E3 reduced the [Ca2+]i rise in response to H2O2 (Fig. 6A). Similarly,
aortic SMCs from Trpm2 knockout mice showed a much smaller [Ca2+]i
response to H2O2, compared with those from wild-type mice (Fig. 6B).
In order to determine whether the Ca2+ increases actually mediate
the proliferation and migration of VSMCs, we applied EGTA (3 mM)
into the culture medium of rodent aortic SMCs and reduced the
extracellular Ca2+ concentration from ~ 1.8 mM to ~ 80 nM (close to
the resting cytosolic Ca2+ level). In scratch wound healing assay, both
the basal and H2O2-induced cell migration were dramatically inhibited
by EGTA (Fig. 7A). In MTT assay, application of EGTA abolished the
H2O2-stimulated cell proliferation (Fig. 7B).
These data indicate that TRPM2 is functionally involved in the
migration and proliferation of cultured VSMCs and reinforce the
forenamed results that Trpm2disruption reduced neointimal hyperplasia.
3.4. TRPM2 mediates ROS-induced activation of Axl/Akt pathway in VSMCs
We further explored the signaling pathway downstream of TRPM2.
It has been previously reported that H2O2 activates Axl (a redox-
sensitive receptor tyrosine kinase) and its downstream Akt pathway
to induce VSMC migration and proliferation [28,29]. Here, we blocked
Akt with either Akt inhibitor IV that targets the ATP-binding site of a
kinase upstream of Akt, or Akt inhibitor X that suppresses the kinase
reactivity of Akt by inhibiting its phosphorylation. It was found thatproliferation and neointimal hyperplasia. Cuff placement induces reactive oxygen species
h TRPM2 channels induces the phosphorylation of Axl and Akt. The activation of Axl/Akt
eointimal hyperplasia. However, the exact mechanism by which the TRPM2-mediated
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H2O2-stimulated migration and proliferation of rat aortic SMCs
(Fig. 8A, B). H2O2 rapidly induced Axl and Akt phosphorylation in rat
aortic SMCs in a time-dependentmanner. The phosphorylation reached
the maximums in 10 min and afterwards decayed. H2O2 treatment did
not affect the total protein levels of Axl and Akt (Fig. 8C). More impor-
tantly, inhibiting TRPM2 by pre-treating the rat aortic SMCs with
TM2E3 (10 μg/ml) for 2 h dramatically suppressed theH2O2-induced ac-
tivation of Axl and Akt (Fig. 8D). The activation of Axl and Akt was
abolished by chelating Ca2+ in culture medium with EGTA (3 mM)
(Fig. 8D). In addition, R428 (5 μM), a selective small-molecule inhibitor
of Axl tyrosine kinase activity, reduced the activation of Akt (Fig. 8D).
These results suggest that TRPM2 mediates the H2O2-induced VSMC
migration and proliferation via the downstream Axl/Akt signaling
pathway.
4. Discussion
The major ﬁndings of the present study are as follows: 1) Cuff injury
of rat femoral arteries induced neointimal hyperplasia, accompanied by
an up-regulation of TRPM2 protein expression in neointimal SMCs.
Furthermore, ROSwere over-produced and PCNA-positive proliferating
cells were numerous in the neointimal region. The neointimal SMCs
isolated from the cuff-injured arteries displayed a greater TRPM2-
mediated [Ca2+]i response to ROS challenge than the normal SMCs
fromnon-cuffed arteries. 2) In cuff injurymodel, neointimal hyperplasia
was markedly reduced in Trpm2 knockout mice compared with wild-
type mice. PCNA expression was also reduced in Trpm2 knockout
mice. 3) Inhibiting TRPM2 by TM2E3 attenuated the H2O2-induced
migration and proliferation of rat aortic SMCs. The migration and
proliferation of aortic SMCs were also reduced in Trpm2 knockout
mice. 4) TM2E3 substantially inhibited the H2O2-induced activation of
Axl/Akt pathway in rat aortic SMCs. Taken together, these data strongly
suggest that TRPM2 channels contribute to the progression of neointi-
mal growth by enhancing VSMC migration and proliferation.
Rodent model of cuff-induced neointimal hyperplasia was employed.
Cuff placementﬁrst causes inﬂammatory responses that result in leuko-
cyte inﬁltration and endothelial injury. The subsequent processes are
the migration of VSMCs from media layer to intima layer where they
proliferate, together with deposition of extracellular matrix, to form
the main elements of neointima [30,31]. These steps well imitate the
development of human atherosclerosis [32]. In addition, this model, to
certain degree, mimics the mechanical damage resulted from human
angioplasty and bypass surgery [9]. In clinical practice, although angio-
plasty and bypass surgery usually recovers the coronary blood ﬂow,
many patients experience vascular restenosis (re-formation of neointi-
ma) afterward, mainly due to surgery-related mechanical damage [2].
Based on these reasons, animal models of cuff-injury have been
developed to explore the mechanisms of neointimal formation and its
treatment options [9,23]. This model is widely used and has been
proven to be reproducible and easily quantiﬁable [9,23]. In experi-
ments, we found that ROS were over-produced and TRPM2 expression
was up-regulated in the SMCs in neointimal and adjacent medial
regions of cuff-injured arteries. Because TRPM2 is a cellular sensor for
ROS, it is envisaged that ROS act on TRPM2 to induce excessive Ca2+
inﬂux, triggering pathological responses and resulting in neointimal
growth. To its support, we found that Trpm2 knockout mice displayed
much reduced neointimal hyperplasia. These results strongly suggest
that TRPM2 is an important mediator in neointimal growth and that
inhibiting TRPM2 could be a means to prevent neointimal growth.
The mechanism of TRPM2 involvement in neointimal hyperplasia
was explored. A major causative factor for neointimal growth is
excessive production of ROS. At sites of vessel injury, ROS are over-
produced by inﬂammatory cells andVSMCs. The accumulated ROS stim-
ulate migration of VSMCs from media layer to the neointimal region,
and enhance VSMC proliferation [5,6,10,33]. These events promoteneointimal growth and facilitate the progression of atherosclerotic
lesions [5,10,33]. TRPM2 is a ROS-sensitive Ca2+-permeable channel
[17,19]. Thus it is reasonable to suggest that ROS may activate TRPM2
in VSMCs to cause a cytosolic Ca2+ rise, which then serves as a second
messenger to stimulate VSMC migration and proliferation. In experi-
ments, we found that TRPM2 was predominantly expressed in SMCs
in neointimal regions in rodent model of neointimal hyperplasia.
Furthermore, TRPM2-mediated Ca2+ response to ROS was much larger
in neointimal SMCs derived from cuff-injured arteries than in normal
SMCs from non-cuffed arteries. In scratch wound healing assay, H2O2
treatment enhanced the migration of rodent aortic SMCs. In EdU incor-
poration assay andMTT assay, H2O2 treatment stimulated SMC prolifer-
ation. Importantly, blocking TRPM2 by TM2E3 or Trpm2 knockout
markedly reduced the migration and proliferation of the SMCs. These
data support the notion that ROS act through TRPM2 to stimulate the
migration and proliferation of VSMCs as a possible underlying mecha-
nism for neointimal growth and atherosclerotic progression. Previous
studies have shown that several other Ca2+-permeable channels,
including TRPC4, TRPC5, TRPC6 and Orai1, may also be involved in the
migration and proliferation of VSMCs [34–37]. However, there is lack
of evidence as towhether these other channels play a role in neointimal
hyperplasia of blood vessels.
Axl is a redox-sensitive receptor tyrosine kinase. It has been reported
that H2O2 can activate Axl to facilitate VSMC migration via an Akt-
dependent pathway [28,29]. In addition, neointima formation in
response to cuff injury was reduced in Axl knockout mice compared
with Axl wild-type mice [28]. Here we found that H2O2 induced Ca2+
inﬂux via TRPM2 channel in rodent aortic SMCs, and that inhibiting
TRPM2 or chelating extracellular Ca2+ almost abolished the H2O2-
induced phosphorylation of Axl and Akt. These data indicate that Axl/
Akt may be the signaling pathway downstream of TRPM2 in VSMC
activation and neointimal hyperplasia. However, it remains unclear
how TRPM2 activation induces Axl/Akt phosphorylation. Reports
show that Axl is activated by its endogenous ligand Gas6, a growth fac-
tor that belongs to the vitamin K-dependent protein family [28,38].
Thus, it is possible that Ca2+ inﬂux via TRPM2 channels might induce
the production of Gas6, which acts on Axl via an autocrine/paracrine
mechanism and results in the phosphorylation of Axl and Akt. However,
further studies are needed to clarify this issue.
Previously, another TRP isoform, TRPC1, has been suggested to be
involved in neointimal growth [22]. In that study, inhibiting TRPC1
with a TRPC1-speciﬁc blocking antibody was found to reduce neointi-
mal hyperplasia of in vitro cultured human saphenous vein [22]. Howev-
er, the role of TRPC1 in neointimal growth is controversial. A later study
reported no difference in neointimal formation between wild-type and
Trpc1 knockout mice [39]. Here, with the use of Trpm2 knockout mice,
we provided convincing evidence for a critical role of TRPM2 in neointi-
mal growth. The results also highlight an exciting possibility of targeting
TRPM2 as a possible therapeutic option for the treatment of neointimal
hyperplasia and/or restenosis. Up to the present, almost no effective
therapeutic option is available for the treatment or prevention of
atherosclerotic neointimal formation, except for lipid-lowering drugs
[40,41]. In this regard, TRPM2 is a membrane channel protein, which
can be easily accessed by chemical and immunological agents. TM2E3
is a blocking antibody highly speciﬁc to TRPM2 [27], therefore it offers
an attractive option to reduce neointimal growth. However, further
study is needed to determine the efﬁcacy and potency of TM2E3 to
TRPM2 as well as its toxicity before the strategy can be further
considered.
5. Conclusion
Wedemonstrated that TRPM2 plays an important role in neointimal
growth of blood vessels. Its role in neointimal hyperplasia is related,
at least partly, to its modulating action on VSMC migration and pro-
liferation via Axl/Akt signaling pathway (Fig. 9). As a ROS-sensitive
1371X. Ru et al. / Biochimica et Biophysica Acta 1852 (2015) 1360–1371Ca2+-permeable channel, the identiﬁcation of TRPM2 links excessive
ROS to Ca2+ entry and VSMC activation in neointimal hyperplasia,
and makes TRPM2 a highly promising drug target for therapy of
occlusive vascular diseases.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbadis.2015.03.014.
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